I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
1.070
-0.020 (-1.83%)
Jan 22, 2025, 4:00 PM EST - Market closed
I-Mab Market Cap
I-Mab has a market cap or net worth of $87.21 million as of January 23, 2025. Its market cap has decreased by -50.67% in one year.
Market Cap
87.21M
Enterprise Value
-93.40M
1-Year Change
-50.67%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $87.21M, a decrease of -36.83%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2025 | 87.21M | 25.88% |
| Dec 31, 2024 | 69.28M | -56.07% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.91B |
| UnitedHealth Group | 478.29B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.76B |
| AbbVie | 299.00B |
| Merck & Co. | 242.01B |
| Thermo Fisher Scientific | 219.78B |
| Intuitive Surgical | 217.43B |